SAN

76.26

-1.73%↓

UCB

250.1

-3.1%↓

SHL.DE

40.38

-0.02%↓

ARGX

620.4

-1.02%↓

PHIA

24.97

-2.19%↓

SAN

76.26

-1.73%↓

UCB

250.1

-3.1%↓

SHL.DE

40.38

-0.02%↓

ARGX

620.4

-1.02%↓

PHIA

24.97

-2.19%↓

SAN

76.26

-1.73%↓

UCB

250.1

-3.1%↓

SHL.DE

40.38

-0.02%↓

ARGX

620.4

-1.02%↓

PHIA

24.97

-2.19%↓

SAN

76.26

-1.73%↓

UCB

250.1

-3.1%↓

SHL.DE

40.38

-0.02%↓

ARGX

620.4

-1.02%↓

PHIA

24.97

-2.19%↓

SAN

76.26

-1.73%↓

UCB

250.1

-3.1%↓

SHL.DE

40.38

-0.02%↓

ARGX

620.4

-1.02%↓

PHIA

24.97

-2.19%↓

Search

Carl Zeiss Meditec AG

Closed

SectorHealthcare

25.2 -0.16

Overview

Share price change

24h

Current

Min

25.18

Max

25.84

Key metrics

By Trading Economics

Income

52M

80M

Sales

-161M

467M

P/E

Sector Avg

23.392

66.845

EPS

0.03

Dividend yield

1.4

Profit margin

12.778

Employees

5,784

EBITDA

124M

187M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+34.79% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.40%

2.25%

Next Earnings

12 maj 2026

Market Stats

By TradingEconomics

Market Cap

-168M

3.5B

Previous open

25.36

Previous close

25.2

News Sentiment

By Acuity

17%

83%

25 / 351 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

Carl Zeiss Meditec AG Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

8 kwi 2025, 08:20 UTC

Market Talk

Med-Tech Investors Seek 'Safe Havens' Amid Tariff Fears -- Market Talk

Peer Comparison

Price change

Carl Zeiss Meditec AG Forecast

Price Target

By TipRanks

34.79% upside

12 Months Forecast

Average 34.21 EUR  34.79%

High 53 EUR

Low 22.4 EUR

Based on 10 Wall Street analysts offering 12 month price targets forCarl Zeiss Meditec AG - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

10 ratings

0

Buy

9

Hold

1

Sell

Technical Score

By Trading Central

58.75 / 60.35Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Weak Bearish Evidence

Sentiment

By Acuity

25 / 351 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.
help-icon Live chat